Brian Kotzin

Brian Kotzin

Directeur/Membre du Conseil chez RIGEL PHARMACEUTICALS, INC.

Fortune : 85 988 $ au 30/04/2024

74 ans
Health Technology
Consumer Services
Health Services

Profil

Brian L.
Kotzin
is currently an Independent Director at Rigel Pharmaceuticals, Inc., a Director at Benaroya Research Institute at Virginia Mason, an Independent Director at Biora Therapeutics, Inc., an Independent Director at Kyverna Therapeutics, Inc., a Director at Genascence Corp., a Non-Executive Director at argenx SE, a Member of the Association of American Physicians, and a Member of the American Society of Clinical Investigation.
Previously, Dr. Kotzin held positions as the Chairman-Immunological Sciences Study Section at the National Institutes of Health, the Director-Autoimmunity Centre of Excellence at the University of Colorado Health Sciences Center, a Director at the American College of Rheumatology, a Director at the Federation of Clinical Immunology Societies, and a Director at Vera Therapeutics, Inc. He also served as the Director & Head-Clinical Immunology at the Autoimmunity Center of Excellence from 1998 to 2004, the VP-Global Clinical Development & Head-Inflammation at Amgen, Inc. from 2004 to 2015, and the Chief Medical Officer & Senior Vice President at Nektar Therapeutics from 2017 to 2023.
Additionally, he was the Chief-Rheumatology Section at the Veterans Administration Medical Center and a Professor at National Jewish Health, Inc.Dr. Kotzin completed his undergraduate studies at the University of Southern California and obtained his doctorate from Stanford University School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/01/2024 75 000 ( 0,04% ) 82 500 $ 30/04/2024
01/03/2024 5 746 ( 0,02% ) 3 488 $ 30/04/2024
01/03/2024 0 ( -.--% ) - $ 30/04/2024

Postes actifs de Brian Kotzin

SociétésPosteDébut
RIGEL PHARMACEUTICALS, INC. Directeur/Membre du Conseil 25/08/2017
BIORA THERAPEUTICS, INC. Directeur/Membre du Conseil 01/06/2019
KYVERNA THERAPEUTICS, INC. Directeur/Membre du Conseil 01/08/2019
ARGENX SE Directeur/Membre du Conseil 07/05/2024
Directeur/Membre du Conseil -
Corporate Officer/Principal -
American Society of Clinical Investigation Corporate Officer/Principal -
Directeur/Membre du Conseil -
Tous les postes actifs de Brian Kotzin

Anciens postes connus de Brian Kotzin

SociétésPosteFin
NEKTAR THERAPEUTICS Directeur Technique/Scientifique/R&D 17/04/2023
░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
Voir l'expérience en détail de Brian Kotzin

Formation de Brian Kotzin

University of Southern California Undergraduate Degree
Stanford University School of Medicine Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Brian Kotzin

Relations

100 +

Relations au 1er degré

19

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées7
AMGEN INC.

Health Technology

NEKTAR THERAPEUTICS

Health Technology

RIGEL PHARMACEUTICALS, INC.

Health Technology

ARGENX SE

Health Technology

KYVERNA THERAPEUTICS, INC.

Health Technology

VERA THERAPEUTICS, INC.

Health Technology

BIORA THERAPEUTICS, INC.

Health Services

Entreprise privées9

Health Services

American Society of Clinical Investigation

Commercial Services

Commercial Services

Health Services

Federation of Clinical Immunology Societies

Health Technology

Autoimmunity Center of Excellence

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Brian Kotzin